Erratum: Rodriguez et al. substance p antagonism as a novel therapeutic option to enhance efficacy of cisplatin in triple negative breast cancer and protect pc12 cells against cisplatin-induced oxidative stress and apoptosis. cancers 2021, 13, 3871

Emma Rodriguez, Guangsheng Pei, Zhongming Zhao, Sang T. Kim, Alexis German, Prema Robinson

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: Rodriguez et al. substance p antagonism as a novel therapeutic option to enhance efficacy of cisplatin in triple negative breast cancer and protect pc12 cells against cisplatin-induced oxidative stress and apoptosis. cancers 2021, 13, 3871'. Together they form a unique fingerprint.

Medicine & Life Sciences